相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Associations of meningioma molecular subgroup and tumor recurrence
Mark W. Youngblood et al.
NEURO-ONCOLOGY (2021)
The effect of the revised WHO classification on the incidence of grade II meningioma
Lindsey S. Bulleid et al.
BRITISH JOURNAL OF NEUROSURGERY (2020)
Developmental biology of the meninges
Krishnakali Dasgupta et al.
GENESIS (2019)
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas
Sally R. Williams et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2019)
Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation
Julien Boetto et al.
ONCOGENE (2018)
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
Tareq A. Juratli et al.
ACTA NEUROPATHOLOGICA (2018)
The Tentorium Cerebelli: A Comprehensive Review Including Its Anatomy, Embryology, and Surgical Techniques
Rabjot Rai et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
Contribution of cranial neural crest cells to mouse skull development
Taofen Wu et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2017)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Victoria E. Clarke et al.
NATURE GENETICS (2016)
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
Malak Abedalthagafi et al.
NEURO-ONCOLOGY (2016)
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu et al.
NATURE (2015)
PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss
Matthieu Peyre et al.
ONCOTARGET (2015)
High Incidence of Activating TERT Promoter Mutations in Meningiomas Undergoing Malignant Progression
Stephane Goutagny et al.
BRAIN PATHOLOGY (2014)
Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases
Jan Frederick Cornelius et al.
ACTA NEUROCHIRURGICA (2013)
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2013)
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
Anatomic Location Is a Risk Factor for Atypical and Malignant Meningiomas
Ari J. Kane et al.
CANCER (2011)
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes
M. Kalamarides et al.
ONCOGENE (2011)
Development and tissue origins of the mammalian cranial base
B. McBratney-Owen et al.
DEVELOPMENTAL BIOLOGY (2008)
World Health Organization Grades II and III meningiomas are rare in the cranial base and spine
Burak Sade et al.
NEUROSURGERY (2007)
Histological classification and molecular genetics of meningiomas
Markus J. Riemenschneider et al.
LANCET NEUROLOGY (2006)
NF2 mutations in secretory and other rare variants of meningiomas
C Hartmann et al.
BRAIN PATHOLOGY (2006)
Relations and interactions between cranial mesoderm and neural crest populations
DM Noden et al.
JOURNAL OF ANATOMY (2005)
Tissue origins and interactions in the mammalian skull vault
XB Jiang et al.
DEVELOPMENTAL BIOLOGY (2002)
NF2 status of meningiomas is associated with tumour localization and histology
J Kros et al.
JOURNAL OF PATHOLOGY (2001)
分享论文
